Jay Stout - 22 Oct 2025 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Chief Technology Officer
Signature: /s/ Tiago Girao, attorney-in-fact for Jay Stout
Issuer symbol: IMVT
Transactions as of: 22 Oct 2025
Transactions value $: -$47,956
Form type: 4
Filing time: 24 Oct 2025, 16:36:56 UTC
Previous filing: 10 Oct 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Stout Jay S	Chief Technology Officer	C/O IMMUNOVANT, INC., 320 W 37TH STREET, 6TH FLOOR, NEW YORK	/s/ Tiago Girao, attorney-in-fact for Jay Stout	24 Oct 2025	0001702969

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Sale	-$48K	-2.52K	-1.24%	$19.03	201K	22 Oct 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on October 17, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2	The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.03 - $19.23 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.

Content

On April 17, 2023, the holder was granted 100,000 restricted stock units ("RSUs"), as previously reported on a Form 4 filed on April 19, 2023, of which 6,250 of these RSUs vested on October 17, 2025. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of these RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.03 - $19.23 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.